Download Files:
FTO-IN-1 (TFA)
SKU
HY-138843A-10 mg
Category Reference compound
Tags Cancer; Metabolic Disease, Fat Mass and Obesity-associated Protein (FTO), Metabolic Enzyme/Protease
$190 – $510
Products Details
Product Description
– FTO-IN-1 TFA is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC50 of <1 μM. FTO-IN-1 TFA can be used for the research of cancer[1].
Web ID
– HY-138843A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C20H17Cl2F3N4O4
References
– [1]Yang C, et, al. 2-(substituted benzene matrix) aromatic formate fto inhibitor, preparation method therefor, and applications thereof. WO2018157843A1.
CAS Number
– 2797619-81-7
Molecular Weight
– 505.27
Compound Purity
– 98.04
SMILES
– O=C(NO)C1=CC=CC=C1NC2=C(Cl)C=C(C3=C(C)NN=C3C)C=C2Cl.OC(C(F)(F)F)=O
Clinical Information
– No Development Reported
Research Area
– Cancer; Metabolic Disease
Solubility
– DMSO : 50 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Fat Mass and Obesity-associated Protein (FTO)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.